# Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin

> **NCT01648023** · PHASE2 · COMPLETED · sponsor: **Robert C. Martin** · enrollment: 49 (actual)

## Conditions studied

- Unresectable Intrahepatic Cholangiocarcinoma

## Interventions

- **DEVICE:** LC or ONCOZENE Bead with Gem-Cis or Gem-Carbo
- **DRUG:** Gem-Cis or Gem-Carbo

## Key facts

- **NCT ID:** NCT01648023
- **Lead sponsor:** Robert C. Martin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2019-01
- **Final completion:** 2019-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648023, "Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01648023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*